Ardent Health Faces Class Action Lawsuit Over Misleading Financials
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Source: Globenewswire
- Financial Misstep Revealed: Ardent Health admitted in its Q3 2025 earnings report that a change in accounting methods led to a $42.6 million revenue reduction, directly impacting investor confidence and triggering a class action lawsuit.
- Misleading Statements Investigation: The lawsuit alleges that Ardent misled investors for over a year by assuring them of effective revenue recognition systems, while in reality, it relied on a 180-day cliff for reserves, leading to a 33% drop in stock price upon disclosure.
- Rising Operating Costs: Ardent also revealed that an increase in professional liability reserves by $47.2 million contributed to a rise in total operating expenses as a percentage of total revenue, further exacerbating market concerns about its financial health.
- Investor Loss Alert: Hagens Berman urges investors who purchased Ardent securities between July 18, 2024, and November 12, 2025, to contact them for potential compensation, reflecting a strong distrust in the company's future.
Analyst Views on ARDT
Wall Street analysts forecast ARDT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARDT is 13.73 USD with a low forecast of 10.00 USD and a high forecast of 17.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Analyst Rating
8 Buy
4 Hold
1 Sell
Moderate Buy
Current: 8.560
Low
10.00
Averages
13.73
High
17.00
Current: 8.560
Low
10.00
Averages
13.73
High
17.00
About ARDT
Ardent Health, Inc., formerly Ardent Health Partners, Inc., is a provider of healthcare in mid-sized urban communities across the United States. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 affiliated providers across six states. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers (ASCs), urgent care centers, free-standing emergency departments, and diagnostic imaging centers. It operates a consumer-centric healthcare platform focused on creating relationships with its patients across multiple care settings.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
